Table 1.
Relevant characteristics of the study group
| Intervention (n = 15) | Control (n = 15) | Overall (n = 30) | |
|---|---|---|---|
| Demographic profile, mean (SD) | |||
| Age (years) | 55.3 (12.6) | 54.9 (9.7) | 55.1 (11.0) |
| Medical profile, mean (SD) | |||
| Weight (kg) | 54.8 (9.6) | 56.7 (10.0) | 55.8 (9.7) |
| BMI (kg/m2) | 22.4 (4.3) | 23.0 (4.2) | 22.7 (4.2) |
| Chemotherapy, n (%) | |||
| High emetic risk | 8 (53.3) | 10 (66.7) | 18 (60.0) |
| Moderate emetic risk | 7 (46.7) | 5 (33.3) | 12 (40.0) |
| Taxotere or docetaxel use | 3 (20.0) | 4 (26.7) | 7 (23.3) |
| Palonosetoron use, n (%) | |||
| 0.75 mg | 13 (86.7) | 14 (93.3) | 27 (90.0) |
| 0.30 mg | 2 (13.3) | 1 (6.7) | 3 (10.0) |
SD standard deviation